Advertisement

Molecular and Cellular Biochemistry

, Volume 392, Issue 1–2, pp 281–287 | Cite as

Maslinic acid induced apoptosis in bladder cancer cells through activating p38 MAPK signaling pathway

  • Shilong ZhangEmail author
  • Degang Ding
  • Xiangsheng Zhang
  • Lei Shan
  • Zhonghua Liu
Article

Abstract

Bladder cancer is among the most aggressive human malignant carcinoma and always showed resistance to traditional chemotherapy based on DNA damaging drugs. Unlike the existing drugs that damage nuclear acid molecules, maslinic acid (MA) displays anti-tumor function in various types of cancers by targeting specific intracellular signaling pathways and is regarded as a promising agent for future clinical cancer therapy. However, its effect on bladder cancer is still unknown. In this study, we assessed the influence of MA on survival of bladder cancer cells and the involved mechanisms. MTT assay showed that MA suppressed the viability of bladder cancer cells. We further confirmed the growth-suppressing activity of MA on T24 and 253J xenograft tumor in mouse models. Subsequently, we found that MA induced apoptosis in bladder cancer cells. Based on immunoblotting assay, we determined that p38 MAPK pathway was greatly activated in MA-treated bladder cancer cells. SB203580 inhibition of p38 MAPK rescued the MA-induced apoptosis of bladder cancer cells. In conclusion, we provided evidences that MA efficiently suppressed activation of p38 MAPK pathways and induced apoptosis of bladder cancer cells.

Keywords

Maslinic acid Bladder cancer p38 MAPK Natural product 

References

  1. 1.
    Martyn-Hemphill C, Mak D, Khan MS, Challacombe BJ, Bishop CV (2013) Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder. Int J Surg 11:749–752PubMedCrossRefGoogle Scholar
  2. 2.
    Witjes JA, Kolli PS (2008) Apaziquone for non-muscle invasive bladder cancer: a critical review. Expert Opin Investig Drugs 17:1085–1096PubMedCrossRefGoogle Scholar
  3. 3.
    Huang L, Guan T, Qian Y, Huang M, Tang X, Li Y, Sun H (2011) Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B. Eur J Pharmacol 672:169–174PubMedCrossRefGoogle Scholar
  4. 4.
    Guan T, Qian Y, Tang X, Huang M, Huang L, Li Y, Sun H (2011) Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT-1 up-regulation. J Neurosci Res 89:1829–1839PubMedCrossRefGoogle Scholar
  5. 5.
    Wen X, Zhang P, Liu J, Zhang L, Wu X, Ni P, Sun H (2006) Pentacyclic triterpenes. Part 2: synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors. Bioorg Med Chem Lett 16:722–726PubMedCrossRefGoogle Scholar
  6. 6.
    Siewert B, Pianowski E, Csuk R (2013) Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28. Eur J Med Chem 70:259–272PubMedCrossRefGoogle Scholar
  7. 7.
    Reyes-Zurita FJ, Rufino-Palomares EE, Medina PP, Leticia Garcia-Salguero E, Peragon J, Cascante M, Lupianez JA (2013) Antitumour activity on extrinsic apoptotic targets of the triterpenoid maslinic acid in p53-deficient Caco-2 adenocarcinoma cells. Biochimie 95:2157–2167PubMedCrossRefGoogle Scholar
  8. 8.
    Sanchez-Tena S, Reyes-Zurita FJ, Diaz-Moralli S, Vinardell MP, Reed M, Garcia-Garcia F, Dopazo J, Lupianez JA, Gunther U, Cascante M (2013) Maslinic acid-enriched diet decreases intestinal tumorigenesis in Apc(Min/+) mice through transcriptomic and metabolomic reprogramming. PLoS One 8:e59392PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Rufino-Palomares EE, Reyes-Zurita FJ, Garcia-Salguero L, Mokhtari K, Medina PP, Lupianez JA, Peragon J (2013) Maslinic acid, a triterpenic anti-tumoural agent, interferes with cytoskeleton protein expression in HT29 human colon-cancer cells. J Proteomics 83:15–25PubMedCrossRefGoogle Scholar
  10. 10.
    Park SY, Nho CW, Kwon DY, Kang YH, Lee KW, Park JH (2013) Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1alpha signalling. Br J Nutr 109:210–222PubMedCrossRefGoogle Scholar
  11. 11.
    Parra A, Rivas F, Martin-Fonseca S, Garcia-Granados A, Martinez A (2011) Maslinic acid derivatives induce significant apoptosis in b16f10 murine melanoma cells. Eur J Med Chem 46:5991–6001PubMedCrossRefGoogle Scholar
  12. 12.
    Lin CC, Huang CY, Mong MC, Chan CY, Yin MC (2011) Antiangiogenic potential of three triterpenic acids in human liver cancer cells. J Agric Food Chem 59:755–762PubMedCrossRefGoogle Scholar
  13. 13.
    Qian Y, Guan T, Tang X, Huang L, Huang M, Li Y, Sun H (2011) Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen–glucose deprivation-induced injury. Eur J Pharmacol 670:148–153PubMedCrossRefGoogle Scholar
  14. 14.
    Murakami C, Myoga K, Kasai R, Ohtani K, Kurokawa T, Ishibashi S, Dayrit F, Padolina WG, Yamasaki K (1993) Screening of plant constituents for effect on glucose transport activity in Ehrlich ascites tumour cells. Chem Pharm Bull (Tokyo) 41:2129–2131CrossRefGoogle Scholar
  15. 15.
    Yadav VR, Prasad S, Sung B, Kannappan R, Aggarwal BB (2010) Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins (Basel) 2:2428–2466CrossRefGoogle Scholar
  16. 16.
    Reyes-Zurita FJ, Pachon-Pena G, Lizarraga D, Rufino-Palomares EE, Cascante M, Lupianez JA (2011) The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism. BMC Cancer 11:154PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, Yamamura S, Ueno K, Dahiya R (2011) Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 4:1698–1709PubMedCentralCrossRefGoogle Scholar
  18. 18.
    Li B, Wu Z, Li W, Jia G, Lu J, Fang J, Chen G (2012) Chlorophyllin e4 is a novel photosensitizer against human bladder cancer cells. Oncol Rep 27:1455–1460PubMedGoogle Scholar
  19. 19.
    Sun Z, Wang H, Ye S, Xiao S, Liu J, Wang W, Jiang D, Liu X, Wang J (2012) Beta-eleostearic acid induce apoptosis in T24 human bladder cancer cells through reactive oxygen species (ROS)-mediated pathway. Prostaglandins Other Lipid Mediat 99:1–8PubMedCrossRefGoogle Scholar
  20. 20.
    Wu DM, Zhao D, Li DZ, Xu DY, Chu WF, Wang XF (2011) Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 383:321–330PubMedCrossRefGoogle Scholar
  21. 21.
    Martin R, Carvalho-Tavares J, Ibeas E, Hernandez M, Ruiz-Gutierrez V, Nieto ML (2007) Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation. Cancer Res 67:3741–3751PubMedCrossRefGoogle Scholar
  22. 22.
    Hsum YW, Yew WT, Hong PL, Soo KK, Hoon LS, Chieng YC, Mooi LY (2011) Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-kappaB and AP-1 activation in Raji cells. Planta Med 77:152–157PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Shilong Zhang
    • 1
    Email author
  • Degang Ding
    • 1
  • Xiangsheng Zhang
    • 1
  • Lei Shan
    • 1
  • Zhonghua Liu
    • 1
  1. 1.Department of Urologic SurgeryPeople’s Hospital of Zhengzhou UniversityZhengzhouChina

Personalised recommendations